# Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes

> **NCT04418739** · PHASE2 · UNKNOWN · sponsor: **Universiti Kebangsaan Malaysia Medical Centre** · enrollment: 122 (estimated)

## Conditions studied

- Pancreaticoduodenectomy
- Pancreatic Fistula
- Delayed Gastric Emptying
- Pancreatic Cancer
- Anastomotic Leak

## Interventions

- **DRUG:** Human albumin

## Key facts

- **NCT ID:** NCT04418739
- **Lead sponsor:** Universiti Kebangsaan Malaysia Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-27
- **Primary completion:** 2022-11-26
- **Final completion:** 2022-11-26
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2022-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04418739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04418739, "Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04418739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*